300111.SZ
向日葵
SZSE · Healthcare · C 制造业 · CN
CNY 2.91
−3.00%Year over year
Reported trailing growth
- Revenue
- -20.4%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -6.8%
- EBITDA
- -20.0%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026